Integral Diagnostics Ltd. (AU:IDX) has released an update.
Capitol Health Limited has announced a merger proposal from Integral Diagnostics, offering Capitol shareholders a 33% premium on their last closing share price. The proposed deal promises significant benefits, including a larger market presence and anticipated annual cost synergies of at least $10 million. Capitol’s board suggests that the merger would create Australia’s largest pure-play publicly listed imaging company, poised for robust growth and improved clinical outcomes.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.
